Cendrine FLEAU has extensive experience in the pharmaceutical industry, currently holding multiple positions at MSD France since 2016, including DH hospital VIH/VHC and DH BU virologie. Cendrine also serves as DH oncologie, focusing on immuno-oncology treatments, specifically Keytruda for melanoma and bladder cancer. Prior experience at MSD France SAS includes a role as déléguée hospitalière in cardiology from 2012 to 2014, and since 2015, Cendrine has been working as déléguée hospitalière for the VIH sector in the BU virologie. Cendrine earned a medical delegate/pharmaceutical delegate degree from the Faculté de pharmacie de Chatenay-Malabry in 2000.
This person is not in the org chart
This person is not in any teams
This person is not in any offices